An article co-published by Salon, NPR, the Boston Globe, and the Tampa Bay Times, discusses the impact of physicians receiving payments from pharmaceutical companies - does it correlate with how they prescribe drugs (name brand or generic?). An analysis by ProPublica is able to provide evidence that a relationship does exist and prescribing habits may be dictated by monies received. Dr. Gellad speaks to the pervasiveness of these payments throughout the profession, as he says, whether those payments are good, bad, or neither.